Loading
Nerve Injury and Regeneration · Journal article
Genetics and Molecular Research · August 12, 2026
A consensus or society position rather than new primary data.
This is a narrative review that organizes neuroplasticity evidence across four mechanistic pillars (synaptic modification, structural remodelling, neurogenesis, and system-level reorganisation) and appraises current interventions in rehabilitation, neurology and psychiatry. It frames plasticity as a non-monotonic, lifespan-dependent, directionally neutral phenomenon and identifies key translational obstacles including biomarker heterogeneity and dose–timing uncertainty, but does not report empirical data or comparative efficacy.
Journal article. Conceptual review applicable across the human lifespan in neurology, psychiatry, pharmacology and rehabilitation medicine..
Plastic capacity follows a non-monotonic lifespan trajectory: high and experience-expectant during critical periods, progressively gated in adulthood, attenuated but not abolished in senescence. Identical mechanisms underwrite both adaptive processes (skill acquisition, recovery) and maladaptive outcomes (central sensitisation, addiction, dystonia, epileptogenesis). Current interventions appraised span task-specific rehabilitation, aerobic exercise, cognitive and social enrichment, structured psychological techniques, sleep and dietary optimisation, neuromodulation, pharmacology, brain-computer interfaces and AI-guided personalisation.
Current interventions appraised span task-specific rehabilitation, aerobic exercise, cognitive and social enrichment, structured psychological techniques, sleep and dietary optimisation, neuromodulation, pharmacology, brain-computer interfaces and AI-guided personalisation.
Clinicians and researchers should recognize that neuroplasticity mechanisms are directionally neutral and lifespan-dependent, that interventional evidence is heterogeneous in maturity, and that the translational challenge now lies in reliable steering of plasticity rather than merely inducing it. The framework may guide selection and timing of interventions but should not be read as evidence of efficacy for any specific modality.
A comprehensive narrative review synthesizing mechanistic and translational evidence on neuroplasticity across the lifespan, organized as a framework for understanding plasticity principles and clinical applications rather than reporting original empirical findings.
Clinicians and researchers should recognize that neuroplasticity mechanisms are directionally neutral and lifespan-dependent, that interventional evidence is heterogeneous in maturity, and that the translational challenge now lies in reliable steering of plasticity rather than merely inducing it. The framework may guide selection and timing of interventions but should not be read as evidence of efficacy for any specific modality.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Neuroplasticity, the capacity of the nervous system to alter its structure, function and connectivity in response to intrinsic and extrinsic stimuli, has moved from a developmental curiosity to a central organising principle of contemporary neuroscience and a plausible therapeutic target across neurology, psychiatry, pharmacology and rehabilitation medicine. This condensed review synthesises current mechanistic and translational evidence within a single integrated framework. Four interdependent pillars of plasticity are delineated: synaptic modification, comprising long-term potentiation, long term depression, spike-timing dependence, metaplasticity and homeostatic scaling; structural remodelling, comprising spine turnover, dendritic and axonal growth, pruning and activity-dependent myelination; neurogenesis; and system-level functional reorganisation, comprising map plasticity, vicariation and diaschisis. These neuron-centred processes are permitted or constrained by a supporting tissue environment of astrocytes, microglia, oligodendrocytes, extracellular matrix and the neurovascular unit, and converge on a common molecular substrate dominated by calcium-dependent glutamatergic signalling, brain-derived neurotrophic factor-TrkB transduction, transcriptional and epigenetic control, and neurosteroid modulation. Plastic capacity follows a non-monotonic lifespan trajectory, being high and experience expectant during critical periods, progressively gated in adulthood, and attenuated but not abolished in senescence. Critically, plasticity is directionally neutral: identical mechanisms underwrite skill acquisition and recovery on the one hand, and central sensitisation, addiction, dystonia and epileptogenesis on the other. The current interventional armamentarium is appraised, spanning task-specific rehabilitation, aerobic exercise, cognitive and social enrichment, structured psychological techniques including clinical hypnosis, sleep and dietary optimisation, non-invasive and paired neuromodulation, plasticity-promoting pharmacology, brain-computer interfaces and artificial-intelligence-guided personalisation, with the maturity of supporting evidence graded for each. Persistent obstacles include biomarker non equivalence, heterogeneity of dose and timing, short follow-up, and unresolved ethical questions concerning equitable access, neural data privacy and the therapy-enhancement boundary. The decisive translational challenge is no longer whether plasticity can be induced, but whether it can be reliably steered.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.